Sign Out
Medglor 90 is indicated for the prevention of thrombotic events (cardiovascular death, myocardial infarction and stroke) in patients with Acute Coronary Syndrome (ACS) (unstable angina, non-ST elevation Myocardial infarction [NSTEMI], or ST elevation Myocardial infarction [STEMI], including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Medglor 90 is indicated to reduced the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA).
Continue with Google